Infera
Control lab instruments with natural language.
Operating in healthcare based in San Francisco, CA, USA, Infera operates.
Profile
Describe an experiment in plain English, and Infera turns it into a validated, instrument-ready run across the equipment your lab already uses. Infera handles the protocol logic, vendor-specific scripts, data, inventory, and institutional knowledge in one system. An AI-native compiler for the lab: one system from intent to execution.
The company sits in the healthcare segment, where it competes on its core product or service.
Its base of operations is San Francisco, CA, USA.
The company is listed at the Spring 2026 stage of development.
Recorded headcount: 2 employees.
Directory analysis
Infera is a San Francisco‑based healthcare startup that turns plain‑English experiment descriptions into instrument‑ready protocols using AI. It bundles protocol logic, vendor‑specific scripts, data handling, inventory management, and institutional knowledge into a single system, allowing labs to run experiments without manual coding. The company focuses on integrating with existing lab equipment to streamline workflow and reduce errors.
Positioning: Infera positions itself as an AI‑native compiler for laboratory workflows, targeting inefficiencies in experimental design and execution. Its emphasis on compatibility with current equipment could give it a niche advantage, though widespread adoption will hinge on technical integration and regulatory approval.
Note: Infera offers a natural‑language interface that converts experiment descriptions into executable lab protocols.
Auto-generated directory analysis from public data · updated 7 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 2 |
| Stage | Spring 2026 |
Website: www.infera.bio
Browse related
Create a free account